Impact of combined HDAC and mTOR inhibition on adhesion, migration and invasion of prostate cancer cells.
about
Therapeutic Value of Voltage-Gated Sodium Channel Inhibitors in Breast, Colorectal, and Prostate Cancer: A Systematic ReviewAmygdalin influences bladder cancer cell adhesion and invasion in vitroSodium channel-inhibiting drugs and cancer survival: protocol for a cohort study using the CPRD primary care databaseSynergistic apoptosis in head and neck squamous cell carcinoma cells by co-inhibition of insulin-like growth factor-1 receptor signaling and compensatory signaling pathways.An automated cell-counting algorithm for fluorescently-stained cells in migration assaysNovel oral histone deacetylase inhibitor, MPT0E028, displays potent growth-inhibitory activity against human B-cell lymphoma in vitro and in vivo.Targeting Histone Deacetylases in Diseases: Where Are We?Vorinostat, an HDAC inhibitor attenuates epidermoid squamous cell carcinoma growth by dampening mTOR signaling pathway in a human xenograft murine model.Inhibition of class I histone deacetylases blunts cardiac hypertrophy through TSC2-dependent mTOR repressionEverolimus exhibits anti-tumorigenic activity in obesity-induced ovarian cancer.Anticancer effects of valproic acid on oral squamous cell carcinoma via SUMOylation in vivo and in vitro.Valproic acid reduces the tolerability of temsirolimus in children and adolescents with solid tumorsHow does cancer cell metabolism affect tumor migration and invasion?RGD-Binding Integrins in Prostate Cancer: Expression Patterns and Therapeutic Prospects against Bone Metastasis.Knockdown of HDAC1 expression suppresses invasion and induces apoptosis in glioma cellsIntensified antineoplastic effect by combining an HDAC-inhibitor, an mTOR-inhibitor and low dosed interferon alpha in prostate cancer cells.GOLPH3 promotes glioblastoma cell migration and invasion via the mTOR-YB1 pathway in vitro.HDAC inhibition suppresses bladder cancer cell adhesion to collagen under flow conditions.Valproic acid inhibits the proliferation of cancer cells by re-expressing cyclin D2.Low dosed interferon alpha augments the anti-tumor potential of histone deacetylase inhibition on prostate cancer cell growth and invasion.Cross-communication between histone H3 and H4 acetylation and Akt-mTOR signalling in prostate cancer cells.HDAC inhibition as a treatment concept to combat temsirolimus-resistant bladder cancer cells.Tip60 regulates MT1-MMP transcription and invasion of glioblastoma cells through NF-κB pathway.The prostate cancer blocking potential of the histone deacetylase inhibitor LBH589 is not enhanced by the multi receptor tyrosine kinase inhibitor TKI258.Valproic acid (VPA) inhibits the epithelial-mesenchymal transition in prostate carcinoma via the dual suppression of SMAD4.HDAC Inhibition Counteracts Metastatic Re-Activation of Prostate Cancer Cells Induced by Chronic mTOR Suppression
P2860
Q26772803-75680673-63AE-4D90-952D-065A82CFB80AQ28543810-799B2C46-92AD-4CB6-B74B-EC6B17CABADFQ28595847-ECFF33AD-46E9-4443-A8E5-FE31E4073A98Q30458494-E55C5BEB-9416-4A0A-9991-7288F34AB00DQ35544076-2982B246-98C1-47EC-8F75-7507A14107D9Q35741591-3741D7BE-F6AD-409F-A442-0C8F07357CD1Q35821728-D1043CFA-0B7A-4A45-9F65-413BC8C798BAQ36501207-5D8CF792-9125-443F-A46D-AE36343F3254Q36812158-D78DF357-E5F2-42EF-8F0F-A6AC15C1C55EQ37190310-B2C31B91-8FC5-4FDE-B42C-7E3B4391DA91Q37581632-7A5C697C-FFFF-4771-A2E8-71C250BDF346Q37733075-FACE930B-DA87-4DBC-8E3E-7725DA908D4DQ38153177-495B3E97-A981-401A-862A-50812799CA3DQ38161395-FBB75B9B-BCA1-4CAB-8EF1-62D80C9ED73CQ38720882-EC206D27-D1BB-48F8-B419-7631E09313ECQ38895320-070D66C6-6FAD-43B2-B630-40F5C8BED6F0Q38962846-CAF815DC-73C7-4C9F-9AA1-2E012C2CC20BQ39100081-B9AD2492-D26B-4B3B-BE6A-E2079162F7AAQ39204978-6A74BC96-07FA-464C-BE10-A4D28E855A02Q39369865-BA572041-F99A-4401-9C5D-06D591B0CDE9Q41874831-02D36711-1643-4599-A1C5-4E0EFB5E8E57Q47100939-460BD705-E005-40A6-9164-9821980F4E87Q52147965-BB9C62DB-677D-4B1B-9E1D-E949D7B64913Q53156735-C90279D6-D883-41BE-9592-06958268DB2FQ53410584-CFEB4036-8519-44F0-BCFC-E52313852920Q58773654-5E6D8A32-E65D-42CD-8D4D-0AF1E6E9D4D5
P2860
Impact of combined HDAC and mTOR inhibition on adhesion, migration and invasion of prostate cancer cells.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Impact of combined HDAC and mT ...... sion of prostate cancer cells.
@en
Impact of combined HDAC and mT ...... sion of prostate cancer cells.
@nl
type
label
Impact of combined HDAC and mT ...... sion of prostate cancer cells.
@en
Impact of combined HDAC and mT ...... sion of prostate cancer cells.
@nl
prefLabel
Impact of combined HDAC and mT ...... sion of prostate cancer cells.
@en
Impact of combined HDAC and mT ...... sion of prostate cancer cells.
@nl
P2093
P2860
P1476
Impact of combined HDAC and mT ...... sion of prostate cancer cells.
@en
P2093
Axel Haferkamp
Christoph Wiesner
Eva Juengel
Igor Tsaur
Jasmina Makarević
Jens-Michael Seibel
Lukasz Hudak
Roman A Blaheta
Steffen Wedel
P2860
P2888
P304
P356
10.1007/S10585-011-9386-8
P577
2011-03-31T00:00:00Z